LSE Intern

Beyond that, the role would also encompass (time permitting) review the entirety of GHU data to produce recommendations on:

• Further analyses that could be conducted on the breadth of data held "as is" - for example that could be commissioned as a specific work-plan to an external Health Economics consortium
• Additional analyses that could be conducted if health outcome data were to be made available, for example by an implementing partner collecting targeted outcome data
• Any other recommendations to the GHU on how it could further utilise the data it collects to the value of increasing domestic financing of NCD care, or demonstrating social return on investment
The Global Health Unit seeking an LSE MSc student with the following profile:
• Currently studying for an MSc in Health Economics, Health Policy, International Health Policy, Health Policy and Economics, or a closely related programme.
• A working understanding of health policy development and implementation in low-resource settings
• Comfort with structured literature review and with synthesising mixed quantitative and qualitative evidence.
• Strong written communication skills, including the ability to translate technical findings for non-specialist policy audiences.
• An interest in the role of cross-sectoral collaboration in healthcare delivery and development in advancing health equity
  
  Better is out there. Better medications, better outcomes, better science. But progress doesn't happen without people - people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen. So, let's be those people.
  
  The GHU has made substantial investment in NCD healthcare programmes across 40 L MIC countries (2022-2026), generating a significant volume of programme data. However, no structured economic case has been developed to demonstrate the value of the GHU's activities in NCD care programmes.
Although the GHU and other non-governmental organisations can improve health in the period in which their programmes operate, care for NCDs must become sustainable for the long term, and securing domestic financing is the key to this. A compelling economic argument that investing in programmes treating NCDs provides a positive impact to the economy is a strong lever to influence domestic health financing decisions. This principle aim of this position is to address that gap by building a health economic evidence base that demonstrates the value of GHU programmes, to support the proposition to governments that increased domestic healthcare financing can be an economic driver rather than a societal cost.